Xudong Wu
xudongwu@nju.edu.cn
English, Chinese
Jiangsu
Nanjing University
Life Sciences
  • 2007.1-2009.9 Joint Ph.D. Program: Virginia Commonwealth University, School of Medicine, Department of Microbiology and Immunology
  • 2004.9-2009.7 Ph.D. in Pharmacology: China Pharmaceutical University
  • 1998.9-2003.7 Bachelor's in Pharmacology: China Pharmaceutical University
  • 2018-present - Nanjing University, School of Life Sciences - Professor and Doctoral Supervisor
  • 2012-2018 - Nanjing University, School of Life Sciences - Associate Professor and Master's Supervisor
  • 2009-2011 - Nanjing University, School of Life Sciences - Lecturer
  • Jiangsu Province Education and Teaching Research Achievement Award (2018): Second Prize
  • Nanjing City 12th Excellent Academic Paper Award in Natural Science (2018): Second Prize
  • Nanjing City 8th Excellent Academic Paper Award in Natural Science (2009): Second Prize
  • American Society for Biochemistry and Molecular Biology (ASBMB) Travel Award (2008)
  • Nanjing University Xinhua News Agency Teaching Award Fund (2019)
New pathogenesis of inflammatory and metabolic diseases, identification of new therapeutic targets
  • CUG-binding protein 1 regulates HSC activation and liver fibrogenesis., Wu Xingxin, Wu Xudong, Ma Yuxiang, Shao Fenli, Tan Yang, Tan Tao, Gu Liyun, Zhou Yang, Sun Beicheng, Sun Yang, Wu Xuefeng, Xu Qiang, 2016
  • HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells., Wu Xudong, Sun Lixin, Zha Weibin, Studer Elaine, Gurley Emily, Chen Li, Wang Xuan, Hylemon PB, Pandak WM Jr, Sanyal AJ, Zhang Luyong, Wang Guangji, Chen Jie, Wang Jian-Ying, Zhou Huiping, 2010
  • Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways., Wu Xudong, Zhang Luyong, Gurley Emily, Studer Elaine, Shang Jing, Wang Tao, Wang Cuifen, Yan Ming, Jiang Zhenzhou, Hylemon PB, Sanyal AJ, Pandak WM Jr, Zhou Huiping, 2008
  • Cis-khellactone inhibited the proinflammatory macrophages via promoting autophagy to ameliorate imiquimod-induced psoriasis., Feng Lili, Song Pingping, Xu Fang, Xu Lisha, Shao Fenli, Guo Mengmeng, Huang Wei, Kong Lingdong, Wu Xudong, Xu Qiang, 2019
  • Seselin ameliorates inflammation via targeting Jak2 to suppress the proinflammatory phenotype of macrophages., Feng Lili, Sun Yi, Song Pingping, Xu Lisha, Wu Xingxin, Wu Xuefeng, Shen Yan, Sun Yang, Kong Lingdong, Wu Xudong, Xu Qiang, 2019
  • HIV protease inhibitors in gut barrier dysfunction and liver injury., Wu Xudong, Li Yunzhou, Peng Kesong, Zhou Huiping, 2014
  • A novel combination of astilbin and low-dose methotrexate respectively targeting A2AAR and its ligand adenosine for the treatment of collagen-induced arthritis., Ma Yuxiang, Gao Zhe, Xu Fang, Liu Li, Luo Qiong, Shen Yan, Wu Xuefeng, Wu Xingxin, Sun Yang, Wu Xudong, Xu Qiang, 2018
  • Neochromine S5 improves contact hypersensitivity through a selective effect on activated T lymphocytes., Gao Zhe, Ma Yuxiang, Zhao Dan, Zhang Xiong, Zhou Hang, Liu Hailiang, Zhou Yang, Wu Xuefeng, Shen Yang, Sun Yang, Li Jianxin, Wu Xudong, Xu Qiang, 2014
  • Pentamethoxyflavanone regulates macrophage polarization and ameliorates sepsis in mice., Feng Lili, Song Pingping, Zhou Hang, Li Ang, Ma Yuxiang, Zhang Xiong, Liu Hailiang, Xu Ge, Zhou Yang, Wu Xuefeng, Shen Yan, Sun Yang, Wu Xudong, Xu Qiang, 2014
  • CPT-11 activates NLRP3 inflammasome through JNK and NF-κB signalings., Li Qian, Zhang Xiong, Wang Weicheng, Li Li, Xu Qiang, Wu Xudong, Gu Yanhong, 2015
  • The role of CCAAT enhancer-binding protein homologous protein in human immunodeficiency virus protease-inhibitor-induced hepatic lipotoxicity in mice., Wang Yun, Zhang Luyong, Wu Xudong, Gurley EC, Kennedy E, Hylemon PB, Pandak WM, Sanyal AJ, Zhou H, 2013
Inflammation Metabolic Diseases Pathogenesis Therapeutic Targets Immune Cells Metabolic Syndrome Autoimmune Diseases Macrophages Nafld Triglyceride Metabolism

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.